Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03885687
Other study ID # 20180508
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 5, 2019
Est. completion date August 1, 2019

Study information

Verified date June 2020
Source University of Miami
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project will test whether the individualized music-enhanced exercise playlist (Exercise with Music intervention) can prevent further physical and psychological deterioration and motivate ICU survivors to more actively participate in their rehabilitation.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date August 1, 2019
Est. primary completion date August 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age = 18 years old

- length of ICU stay >5 days (excludes patients with less comorbidity)

- within 72 hours of ICU discharge (standardizes time to begin intervention)

- ability to independently move upper and lower extremities (required to participate in intervention)

- ability to speak English or Spanish

Exclusion Criteria:

- documented mental incompetence

- dependent status pre-ICU admission (KATZ, activity daily living scale)

- evidence of delirium using the Confusion Assessment Method (CAM)

- hearing impairment

- documented "comfort measures only" in the electronic medical record

- prior residence in a long-term care facility

- unstable hemodynamics

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise with Music
The Exercise with Music intervention is recorded exercise playlist, which provide exercise instructions tailored to patients' musical choices and exercise capacity.
Exercise
The exercise group will receive exercise brochure and will be advised to exercise at least twice daily.

Locations

Country Name City State
United States University of Miami Miami Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Miami

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Enrollment rate Number of subjects enrolled into the study divided by number of subjects approached X 100% One year
Primary Acceptability of intervention as measured by a questionnaire A self-designed 8-item questionnaire is administered to assess subjects' feedback regarding the intervention. Five questions are likert-scale questions (strongly disagree, disagree, undecided, agree, strongly agree); three questions are yes or no questions. If the results of the questionnaire show that majority of patients answer "agree or strongly agree" and "yes", this would indicate that the intervention is acceptable. If the results of the questionnaire show that majority of the patients answer "strongly disagree or disagree" and "no", this would indicate that the intervention is not acceptable. Day five
Primary Number of participants that complete the intervention as prescribed Count of participants who exercise twice daily for five days (upper and lower extremity exercise). Each session includes five movements. The number of movements and sessions of the intervention delivered within and beyond the 5-day mandatory regimen will be documented. Day 5
Primary Number of participants that complete the intervention beyond the 5-day mandatory sessions Count of participants who complete additional exercise sessions beyond the prescribed exercise regimen (twice daily for five days). Each session includes five movements. Day 11
Primary Number of participants with adverse events Adverse events are any untoward medical occurrence in a participant, which does not necessarily have a causal relationship with the trial intervention. Day 5
Secondary Effect size of the Exercise with Music intervention Estimated effect size of the intervention on outcome measures to calculate sample size for a larger future study. One year
Secondary Changes in activity Activity will be monitored using an Actiwatch (Philips Respironics) placed on subjects' wrists at enrollment. The Actiwatch is a small, lightweight, limb-worn activity monitoring device. It contains an accelerometer that is capable of sensing any motion with minimal acceleration of 0.01g to measure long-term gross motor activity and intensity of motion. Baseline, Day 5
Secondary Changes grip strength Grip strength will be assessed using handgrip dynamometer. Baseline, Day 5
Secondary Changes grip strength at hospital discharge Grip strength will be assessed using handgrip dynamometer. Day 5, Day 11
Secondary Changes in Foot Strength Foot strength will be assessed objectively using hand-held dynamometer. Baseline, Day 5
Secondary Changes in Foot Strength at hospital discharge Foot strength will be assessed objectively using hand-held dynamometer. Day 5, Day 11
Secondary Changes in Motivation (Visual Analog Scale) Motivation will be measured by the visual analog scale (VAS) with scores from 0 to 100. "0" indicates "not motivated to do exercise at all"; "100" indicates "extremely motivated to do exercise". Baseline, Day 5
Secondary Changes in Motivation (Visual Analog Scale) at hospital discharge Motivation will be measured by the visual analog scale (VAS) with scores from 0 to 100. "0" indicates "not motivated to do exercise at all"; "100" indicates "extremely motivated to do exercise". Day 5, Day 11
Secondary Changes in Anxiety (Visual Analog Scale) Anxiety will be measured by the visual analog scale (VAS) with scores from 0 to 100. "0" indicates "no anxiety"; "100" indicates "extremely anxious". Baseline, Day 5
Secondary Changes in Anxiety (Visual Analog Scale) at hospital discharge Anxiety will be measured by the visual analog scale (VAS) with scores from 0 to 100. "0" indicates "no anxiety"; "100" indicates "extremely anxious". Day 5, Day 11
Secondary Changes in Anxiety (NIH Toolbox) Anxiety will also be assessed using the NIH Toolbox Emotion Battery (fear-affect survey), CAT format. Each item administered has a 5-point scale with options ranging from "never" to "always." The survey is scored using IRT methods. Higher scores are indicative of more feelings of anxiety. Baseline, day 5
Secondary Changes in Anxiety (NIH Toolbox) at hospital discharge Anxiety will also be assessed using the NIH Toolbox Emotion Battery (fear-affect survey), CAT format. Each item administered has a 5-point scale with options ranging from "never" to "always." The survey is scored using IRT methods. Higher scores are indicative of more feelings of anxiety. Day 5, Day 11
Secondary Changes in Depression (NIH Toolbox) Depression will be assessed using the NIH Toolbox Emotion Battery (sadness survey), CAT format. Each item administered has a 5-point scale with options ranging from "never" to "always" (adults) or "almost always". higher scores are indicative of more depressive. Baseline, Day 5
Secondary Changes in Depression (NIH Toolbox) at hospital discharge Depression will be assessed using the NIH Toolbox Emotion Battery (sadness survey), CAT format. Each item administered has a 5-point scale with options ranging from "never" to "always" (adults) or "almost always". higher scores are indicative of more depressive. Day 5, Day 11
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness